MarketInOut Stock Screener Log In | Sign Up
 

Evogene Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Evogene Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4.95 mln
Float9.96 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.72
Highly reliable

Relative Strength

36 / 100
Underperforming

Debt / Equity

0.36
Low leverage

Pre-Tax Margin

-1,199%
Severely loss-making

ROE

-183
Deeply negative

Business Description

Founded in Israel in 1999, Evogene uses advanced computational tools to drive innovation across agriculture, human health, and industrial markets. In farming, the company works to improve crops and develop new agricultural chemicals, while in medicine it applies AI to create new drug compounds and explore treatments for serious inflammatory conditions. Evogene also develops castor bean seeds for industrial purposes and has a presence in markets spanning the United States, Europe, and Africa.

Key Fundamentals

EPS-1.55
ROE-183
RPS0.17
ROIC-125
ROA-38.41
Interest Cover-2.73
EBITDA, mln-9.80
EV / EBITDA-0.70
EV / EBIT-0.64
Revenue, mln1.31
EV / Revenue5.24

Quote Details

Last 0.3641
Change -0.0118 (-3.14%)
Open 0.3652
Volume 9,099
Turnover 3,312.95
Average Volume 1,867,146

Financial Ratios

Pre-Tax Profit Margin-1,199
Current Ratio3.57
Price / Book0.86
Price / Tangible Book0.86
Debt / Equity0.36
Price / Sales2.58

Financial Strength

Altman Z-Score-31.79
Piotroski F-Score 2 / 9
Beneish M-Score-3.72
Short Ratio0.28
Short % of Float5.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.72% 15 / 100   
1 Month -14.13% 24 / 100   
2 Months -33.73% 14 / 100   
6 Months -53.79% 11 / 100   
1 Year -71.33% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog